Home > Healthcare > Pharmaceuticals > Finished Drug Form > Acetaminophen Market
Acetaminophen Market size accounted for USD 9.8 billion in 2022 and is estimated to grow at a CAGR of 4.8% to reach USD 16.4 billion by 2032. The market is driven by the increasing use of paracetamol in conditions such as flu, fever, and headaches.
Acetaminophen is a commonly used painkiller for headaches and is available without prescription in most parts of the world. Hence, rising cases of infectious diseases and headache disorder is expected to positively influence the market growth. For instance, according to the Global Burden of Disease (GBD) study, headache disorders are among the most prevalent and disabling conditions worldwide. Similarly, as reported by the American Migraine Foundation, migraines affect 1 in 7 people globally. Additionally, acetaminophen when given intravenously acts as an effective treatment option in relieving pain and gives rapid relief.
Acetaminophen, also known as paracetamol, is a common painkiller widely used as an antipyretic and analgesic that relieves pain and reduces fever. Paracetamol is available combined with other painkillers and anti-sickness medicines. The drug is considered as over-the-counter drug and is available under a several brand names.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Acetaminophen Market Size in 2022: | USD 9.8 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 4.8% |
2032 Value Projection: | USD 16.4 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 180 |
Tables, Charts & Figures: | 268 |
Segments covered: | Dosage Form, Route of Administration, Applications, Distribution Channels, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|